Press Release

Glythera-led consortium wins Industrial Biotechnology Catalyst funding

27th July 2015 Glythera-led consortium wins Industrial Biotechnology Catalyst funding   £248,000 to develop high-throughput glycosylation assay Glythera Limited, the next generation Antibody Drug Conjugate (ADC) company, today announces  that, through a consortium with GlycoSeLect Ltd, specialists in the development and production of recombinant prokaryotic lectins and the Biologics unit of the Centre for Process Innovation (CPI), a UK-based technology innovation centre and part of the High Value Manufacturing Catapult, they have been awarded £248,000 by Innovate UK, the UK…

Read more>>

U.K. Continues to Invest in GMP Manufactured Biologics and Advanced Therapies

  Difficult business requires investment in the right infrastructure and skilled people, as well as developing the right processes for efficient and profitable manufacturing. -       Sue Pearson, Ph.D.    At BioProcessUK’s recent meeting in Liverpool, Steve Bates, CEO of the BioIndustry Association (BIA), the trade body for bioscience companies in the U.K., explained how valuable biologics and vaccine manufacturing is to the country, by stating: “The U.K. medicines manufacturing industry, which includes biologics is one of our leading manufacturing sectors;…

Read more>>

Why you should consider a career in Bioscience?

You are passionate about science and technology. You enjoy problem solving. You thrive on being a team-player and want to help people. If this sounds like you then working as a Bio-scientist could be your perfect job!   Imagine working as a virologist studying fascinating tropical diseases; or a clinical scientist assisting with the assessment, diagnosis and treatment of patients; or a pharmacologist investigating the effects of a new drug. Whichever field within Bioscience that you choose to look at,…

Read more>>